Alix-Panabieres, C, Vendrell, JP, Slijper, M, Pellé O, Barbotte E, Mercier G, Jacot W, Fabbro M, Pantel K. (2009). Full- length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer. Breast cancer Res, 11(3):R39.
Allard, WJ, Matera, J, Miller, MC, Repollet, M, Connelly, MC, Rao, C, Tibbe, AG, Uhr, JW, Terstappen, LW. (2004). Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res, 10(20):6897-6904.
American cancer society. Prevention and early detection, Tumor Markers. American cancer society 2015; 29.
Baccelli, I, Schneeweiss, A, Reithdorf, S, Stenzinger, A, Schillert, A, Vogel, V, Klein, C, Saini, M, Bauerle, T, Wallwiener, M, Holland-Letz T, Höfner T, Sprick M, Scharpff M, Marmé F, Sinn HP, Pantel K, Weichert W, Trumpp A. (2013). Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol, 31(6):539-544.
Bernard, PS, Wittwer, CT. (2002). Real-Time PCR technology for cancer diagnostics. Clin Chem, 48(8):1178-1185.
Chu, PG, Weiss, LM. (2002). Keratin expression in human tissues and neoplasms. Histopathology, 40(5):403-439. [PubMed]
Choy, A, McCulloch, PG. (1993). Detection and enumeration of circulating tumor cells in colorectal cancer. Br J Surg, 80:1490.
Cristofanilli, M, Budd, GT, Ellis, MJ, Stopeck, A, Matera, J, Miller, MC, Reuben JM, Doyle, GV, Allard, WJ, Terstappen, LW, Hayes DF. (2004). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med, 351:781-791.
DeSantis, CE, Fedewa, SA, Goding Sauer, A, Goding Sauer A, Kramer JL, Smith RA. (2016), Breast cancer statistics, 2015: convergence of incidence rates between black and white women. Ca cancer J Clin, 66(1):31-42.
Dive, C., Smith RA, Garner E, Ward T, George-Smith SS, Campbell F, Greenhalf W, Ghaneh P, Neoptolemos JP. (2010). Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer. Br J Cancer, 102(3):577-582.
[Internet] WHO: Geneva, Switzerland. Breast cancer .http://www.who.int/cancer/prevention/diagnosis-screening/breast-cancer/en/
Katapodi, MC, Dodd, MJ, Lee, KA, Facione, NC. (2009). Underestimation of Breast Cancer Risk: Influence on Screening Behavior. Oncol Nurs Forum, 36(3):306-314.
Makarovskiy, AN, Ackerley, W, Wojcik, L, Halpert, GK, Stein, BS, Carreiro, MP, Hixson, DC. (1997). Application of immunomagnetic beads in combination with RT-PCR for the detection of circulating prostate cancer cells. J Clin Lab Anal, 11(6):346-350.
Naoe, M, Ogawa, Y, Morita, J, Omori, K, Takeshita, K, Shichijyo, T, Okumura, T, Igarashi, A, Yanaihara, A, Iwamoto, S, Fukagai T, Miyazaki A, Yoshida H. (2007). Detection of circulating urothelial cancer cells in the blood using the CellSearch System. Cancer, 109:1439-1445.
Salehi Nodeh, A, Ghafouri, S, Razavi, S, Mirshafie, SA. (2008). Assessment of TPS tumor marker with ELISA for early detection and monitoring of Breast cancer. Payavard Salamat, 2:84-88.
Schrohl AS, Holten-Andersen M, Sweep F, Schmitt M, Harbeck N, Foekens J, Brünner N. (2003). Tumor markers from laboratory to clinical utility. Mol Cell Proteomics, 2(6):378-387.
Shao, MM, Chan, SK, Yu, AM, Lam, CC, Tsang JY, Lui PC, Law BK, Tan PH, Tse GM. (2012). Keratin expression in breast cancers. Virchows Arch, 461(3):313-322.
Siegel, R., Ma, J, Zou, Z, Jemal, A. (2014). Cancer statistics, 2014. Ca Cancer J Clin, 64(1):9-29. [PubMed]
Siegel, RL, Miller, KD, Jemal, A. (2017). Cancer statistics, 2017, Ca cancer J Clin, 67(1):7-30.
Stevart, BW, Wild, CP. (2014). World Cancer Report, Geneva, Switzerland: WHO press.
Wolfrum, F, Vogel, I, Fandrich, F, Kalthoff, H. (2005). Detection and clinical implications of minimal residual disease in gastro-intestinal cancer. Langenbecks Arch Surg, 390:430-441.
Zhang, L, Ridgway, LD, Wetzel, MD, Ngo, J, Yin, W, Kumar, D, Goodman, JC, Groves, MD, Marchetti, D. (2013). The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci. Transl. Med, 5(180):180ra48.